Cardiac glycosides display selective efficacy for STK11 mutant lung cancer. - Wikidata - awgldk - TriplyDB

Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.

Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.

http://www.wikidata.org/entity/Q37105125

about

A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer.A quantitative shRNA screen identifies ATP1A1 as a gene that regulates cytotoxicity by aurilide B.Transcriptome modeling and phenotypic assays for cancer precision medicine.Na/K Pump and Beyond: Na/K-ATPase as a Modulator of Apoptosis and Autophagy.Digoxin enhances radiation response in radioresistant A549 cells by reducing protein phosphatase 2A.Anticancer and Immunogenic Properties of Cardiac Glycosides.Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.Ouabain suppresses the growth and migration abilities of glioma U‑87MG cells through inhibiting the Akt/mTOR signaling pathway and downregulating the expression of HIF‑1α.

P2860

Q36371799-E82FCF68-8F2D-4B79-A54D-FA8F9FA024C8 Q36374317-CC119EE4-626C-44FA-92F3-5B9B4FCD8B75 Q38400577-BD53349C-2779-49A9-8BBB-8FEF8934C415 Q39254499-45D6EDA8-1F96-4B43-828A-67454B812AB3 Q47146141-315FA9BE-E38F-4EA2-8610-E247E4380D7A Q48341352-21887D9C-7667-4BEF-953D-95AA513E2911 Q50005505-498AA515-B429-45F9-AB06-21550BCC399E Q50047746-CD56EE78-B6A0-452D-B91C-6C7F4D747AAB

P2860

Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.

http://www.wikidata.org/entity/Q37105125

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.

@en

Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.

@nl

type

label

Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.

@en

Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.

@nl

prefLabel

Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.

@en

Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.

@nl

P1433

Q37105125-6F94BC11-E9DA-4388-9AA6-30994F4A3954

P1476

Q37105125-8AE725D8-4EED-4578-9DC1-F14D36B44AC0

P2093

Q37105125-33E03A16-A4A5-4D2D-83D1-1C25C2FA8AC8

Q37105125-434941BE-82C0-4521-A8D7-511E43FE3782

Q37105125-5B331B08-DB11-4D30-BE03-7C2822C35081

Q37105125-876F6740-3505-45CA-8ABD-C28B82ACA7EB

Q37105125-8F35A483-8A3B-4872-B5C5-09623B63DACD

Q37105125-9FA5A339-E43B-4EB8-B1FD-EBBBA899B4B2

Q37105125-AC2AFF9E-1BC7-4ECD-A2BD-67DF4E34B615

Q37105125-ACB0F0B7-7621-41F4-997A-99961AE91EAF

Q37105125-B0899497-4C42-465B-8022-4439949208BA

Q37105125-C2E213AB-DC01-4A7C-8ACD-963EFA234753

P2860

Q37105125-0606EFE1-0BE6-4DD2-921C-6751F72395C5

Q37105125-07156738-7063-4D35-BB97-02360DA0070F

Q37105125-212169CF-D84C-447C-BC4C-94E4444EBB7D

Q37105125-2A848210-18D8-4ED7-9E45-62DE3D7A6366

Q37105125-379BC5D8-D276-4674-955C-4EFDC07B3978

Q37105125-3B93B012-19D7-4F03-B35B-93B8A5DD7142

Q37105125-4411EF14-D457-4416-A00E-2790459FE74C

Q37105125-4DFE2233-C6B1-40B0-B7BC-D9DE4095EA09

Q37105125-5AB9C8C5-8A5C-471E-ACE3-E2C7D015F050

Q37105125-60510679-7B1B-4BB7-9661-E18D3F1F4521

P2888

Q37105125-A095BD48-5246-4BD8-BCEF-6C1742111E73

P304

Q37105125-A4F4CAA8-1623-4F64-A198-6618246E3005

P31

Q37105125-84683DE8-79A5-48D2-A178-05A1C5E87A04

P356

Q37105125-48BA4D1C-E131-4229-A5E3-85CE7DD86F8C

P407

Q37105125-4E40C51B-1114-48B8-A934-8C09BBA7C8C2

P478

Q37105125-549F515F-62C1-43CC-8AF0-FA3263F550EB

P50

Q37105125-3D25E1B4-422C-45C6-B5F6-80C5238BC173

Q37105125-C732FF5C-7F8E-48E3-8B37-FA104C6A34E0

P577

Q37105125-D46E634B-E5B9-4002-BE47-B66F24153969

P698

Q37105125-B6791488-DFC8-4AA7-8FF0-9462318DF7F7

P932

Q37105125-C863A6C8-6C70-4E9F-936B-72F99DFA58DF

P356

P1433

Scientific Reports

P1476

Cardiac glycosides display selective efficacy for STK11 mutant lung cancer

@en

P2093

Cheol-Jung Lee

http://www.w3.org/2001/XMLSchema#string

Euna Jeong

http://www.w3.org/2001/XMLSchema#string

Gordon B Mills

http://www.w3.org/2001/XMLSchema#string

Hwa Young Yim

http://www.w3.org/2001/XMLSchema#string

Hye Suk Lee

http://www.w3.org/2001/XMLSchema#string

Ju Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Mee Song

http://www.w3.org/2001/XMLSchema#string

Nayoung Kim

http://www.w3.org/2001/XMLSchema#string

Ningning He

http://www.w3.org/2001/XMLSchema#string

Somin Kim

http://www.w3.org/2001/XMLSchema#string

P2860

DrugBank 4.0: shedding new light on drug metabolism

Somatic mutations affect key pathways in lung adenocarcinoma

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

The concept of synthetic lethality in the context of anticancer therapy

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

The NCI60 human tumour cell line anticancer drug screen

LKB1 modulates lung cancer differentiation and metastasis

Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth.

Systematic analysis of genotype-specific drug responses in cancer.

P2888

P304

29721

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP29721

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27431571

http://www.w3.org/2001/XMLSchema#string

P932

4949473

http://www.w3.org/2001/XMLSchema#string